DiscoverState of MedtechNon-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement
Non-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement

Non-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement

Update: 2025-08-26
Share

Description

Tetiana Aleksandrova, CEO and founder of Subsense, explains how her team is building a nanoparticle-based Brain Computer Interface designed to treat symptoms of neurological disorders while unlocking new possibilities for human cognition.

Episode Breakdown:00:00 – Opening and long-term vision for merging humans with technology01:10 – Guest introduction: Tetiana Aleksandrova, CEO and founder of Subsense
02:01 – Personal journey: from chemistry to economics to serial BCI entrepreneur03:38 – Lessons learned from her first EEG-based BCI company05:25 – Why Subsense pivoted to nanoparticle-based BCIs06:52 – The problem with current treatments for neurodegenerative diseases07:40 – Non-surgical alternatives to deep brain stimulation09:35 – Nanoparticles as antennas for brain signals12:20 – Duration, delivery methods, and safety of nanoparticles13:04 – First clinical targets: Parkinson’s and epilepsy14:50 – Why non-surgical BCIs excite clinicians and investors16:05 – Expanding into broader neurological disorders and cognitive enhancement17:02 – Device design and hardware considerations18:19 – Why separate nanoparticles are needed for reading and stimulation20:01 – Collaborations with UC Santa Cruz and ETH Zurich21:08 – Regulatory challenges and breakthrough designation pathway22:21 – How stimulation nanoparticles work in the brain25:01 – Potential beyond medicine: memory, focus, and human performance28:14 – Public demand for cognitive optimization since COVID
30:33 – The AI revolution and parallels with the BCI revolution
33:01 – Why BCIs could be the next major technological shift
34:20 – $17M funding round led by Golden Falcon Capital and Palo Alto lab launch
36:45 – Future milestones and how to connect with Subsense

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠GrowMyMedtech.com⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠

Subscribe to our LinkedIn Newsletter

⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠

Follow The State of MedTech on

LinkedIn ⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠

Instagram ⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠

TikTok ⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠

X ⁠⁠https://twitter.com/StateofMedTech⁠⁠

Facebook ⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠

Follow Omar M. Khateeb on

LinkedIn ⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠

Instagram ⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠

TikTok ⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠

X ⁠⁠https://twitter.com/OmarMKhateeb⁠⁠

Facebook ⁠⁠https://www.facebook.com/OmarMKhateeb/⁠

#BCI #Neurotech #Medtech #HealthcareInnovation #BrainComputerInterface #DigitalHealth #Neuroscience


Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Non-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement

Non-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement

State of Medtech